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ABSTRACT
Introduction People with psychosis tend to have smaller 
social networks than both people in the general population 
and other people with long- term health conditions. Small 
social networks are associated with poor quality of life. 
Preliminary evidence suggests that coaching patients to 
increase their social contacts may be effective. In this 
study, we assessed whether structured social coaching 
improves the quality of life of patients with psychosis 
(primary outcome) compared with an active control group, 
receiving information on local social activities.
Methods and analysis A structured social coaching 
intervention was developed based on the literature and 
refined through stakeholder involvement. It draws on 
principles from motivational interviewing, solution focused 
therapy and structured information giving. It is provided 
over a 6- month period and can be delivered by a range 
of different mental health professionals. Its effectiveness 
and cost- effectiveness are assessed in a randomised 
controlled trial, compared with an active control group, 
in which participants are given an information booklet 
on local social activities. Participants are aged 18 or 
over, have a primary diagnosis of a psychotic disorder 
(International Classification of Disease: F20–29) and 
capacity to provide informed consent. Participants are 
assessed at baseline and at 6, 12 and 18 months after 
individual randomisation. The primary outcome is quality 
of life at 6 months (Manchester Short Assessment of 
Quality of Life). We hypothesise that the effects on 
quality of life are mediated by an increase in social 
contacts. Secondary outcomes are symptoms, social 
situation and time spent in social activities. Costs and 
cost- effectiveness analyses will consider service use and 
health- related quality of life.
Ethics and dissemination National Health Service REC 
London Hampstead (19/LO/0088) provided a favourable 
opinion. Findings will be disseminated through a 
website, social media, scientific papers and user- friendly 
reports, in collaboration with a lived experience advisory 
panel.
Trial registration number ISRCTN15815862.
INTRODUCTION
At any given time, more than 200 000 people 
experience a psychotic disorder in England 
alone. The total costs for England was esti-
mated to be £4 billion in 2007 and £6.5 billion 
by 2026.1 People with psychotic disorders have 
much smaller social network sizes compared 
with the general population, and compared 
with other groups with long- term mental and 
physical health problems.2 3 Social isolation is 
not only a serious problem in itself, but is also 
linked with poor quality of life and a range of 
unfavourable health outcomes.3–6
Traditionally, pharmacological and psycho-
logical treatments have attempted to reduce 
the social isolation of patients with psychosis 
indirectly; through treating symptoms or by 
teaching social skills.7 However, the symp-
toms of psychosis which are mostly linked 
with social isolation, that is the ‘negative 
Strengths and limitations of this study
 ► Broad inclusion criteria, allowing inclusion of pa-
tients with a range of individual characteristics (eg, 
varying level of financial difficulties, and different 
types and levels of symptoms).
 ► Inclusion of a large number of urban, semiurban and 
rural sites, as different geographical contexts may influ-
ence the availability or convenience of social activities.
 ► Active control condition, that is, the provision of 
comprehensive information on local social activities.
 ► During this trial, we focused on people of working age 
(18–65) and only included people who are fluent in 
English.
 ► Since social coaching was not part of routine care 
before this trial, the coaches in the experimental in-
tervention are—although trained—not experienced 
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symptoms’ do not show a substantial response to estab-
lished pharmacological treatments.8 Social skills training 
has been found to be effective in teaching these skills to 
patients, however, this does not translate to improved 
social functioning.9 Given the evidence that its benefits 
are limited, social skills training is not recommended by 
National Institute for Health and Care Excellence (NICE) 
guidelines.4
A systematic review by Anderson et al7 found that interven-
tions which directly focused on supporting socialisation activ-
ities had a positive effect on reducing social isolation.10–13 
These interventions were diverse, including guided peer 
support, social coaching and dog- assisted integrative psycho-
logical therapy. The largest and highest quality trial among 
the ones identified tested a social coaching intervention, 
which was the only intervention clearly targeting social 
contacts outside of services.11 This led to the decision that 
this model would inform our intervention development. 
One of the limitations identified by the systematic review was 
that none of the studies reported an economic analysis of 
the costs and benefits of the interventions.7
In a research programme funded by the National Insti-
tute for Health Research (https:// scene. elft. nhs. uk), we 
developed a manualised and structured social coaching 
intervention. The effective components identified in the 
international literature7 were refined and adapted to the 
English National Health Service (NHS) context. The 
intervention was designed to improve patients’ quality of 
life through increasing their social networks.
OBJECTIVES
Primary objective
To assess whether the structured social coaching inter-
vention improves the quality of life of patients with 
psychosis (primary outcome) compared with an active 
control group, which received information on local social 
activities.
Secondary objectives
1. To understand whether changes in quality of life are 
mediated by an increase in social contacts (in the pre-
vious week).
2. To evaluate whether the intervention improves second-
ary outcomes such as social contacts, symptoms, social 
situation, feelings of loneliness, time spent in social 
activities, health- related quality of life and whether it 
reduces service use.
3. To assess costs and cost- effectiveness of the interven-
tion.
4. To explore implementation of the intervention.
METHODS
Study design
Individually randomised, parallel group controlled trial. 
The intervention and control condition are provided in 
addition to standard care.
Study sites
This multicentre study is led and sponsored by East 
London NHS Foundation Trust (https://www. elft. nhs. 
uk/ Contact- Us) and includes the sites listed in box 1. The 




 ► 18–65 years old.
 ► Diagnosis of psychosis- related condition (Interna-
tional Classification of Disease 10th revision, F20–29).
 ► Capacity to provide informed consent.
 ► Ability to communicate in English.
 ► Limited social network size (three or less social 
contacts with non- first degree relatives in the previous 
week).
 ► Low quality of life (score 5 or less on the Manchester 
Short Assessment of Quality of Life (MANSA) quality 
of life assessment).
 ► Not receiving hospital treatment at the time of 
recruitment.
Social coaches:
 ► Mental health professionals with experience of 
providing mental healthcare (eg, psychiatrists, clinical 
psychologists, nursing staff, occupational therapists), 
minimum NHS Band 4 or equivalent experience.
 ► Aged 18 and over.
 ► Capacity to provide informed consent.
 ► Ability to communicate in English.
Intervention development
The intervention developed by Terzian et al11 was taken as 
the starting point for the intervention tested in this trial. It 
was specified and expanded using approaches from solution- 
focused therapy and motivational interviewing, and consid-
ering previous experiences of the group in developing and 
evaluating complex psychosocial interventions, in particular 
DIALOG+.14 It was further modified and then manualised 
by the Programme Management group, which included 
experts in psychiatry, psychology, social work, occupational 
Box 1 Trial sites
 ► East London National Health Service (NHS) Foundation Trust (two 
sites: East London and Luton).
 ► Tees, Esk and Wear valleys NHS Foundation Trust.
 ► Devon Partnership NHS Trust.
 ► Cornwall NHS Partnership NHS Trust.
 ► Oxford Health NHS Foundation Trust.
 ► Somerset NHS Foundation Trust.
 ► Leeds and York NHS Foundation Trust.
 ► Humber Teaching NHS Foundation Trust.
 ► Gloucestershire Health and Care NHS Foundation Trust.
 ► Coventry and Warwickshire Partnership NHS Trust.
 ► Lincolnshire Partnership NHS Trust.
 ► Cambridgeshire and Peterborough NHS Foundation Trust
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therapy, social sciences and behavioural change and experts 
by experience. The intervention was finalised in consulta-
tion with stakeholders.15 The intervention is considered to 
be generic and not profession- specific, so that it can be deliv-
ered by different professional groups. The role of the social 
coach is intended to be independent of other treatment 
and solely focused on the task of expanding social networks. 
Social coaches are not meant to establish a wider or longer- 
term therapeutic relationship, which might interfere with 
other therapeutic relationships of the patients. The theoret-
ical framework used is shown in figure 1.
Randomisation procedures
Patients are individually randomised to either the interven-
tion or control group. The allocation ratio is 1:1. Randomi-
sation is stratified by site (NHS Trust), ensuring balanced 
numbers of patients in each group at each NHS Trust. 
Permuted blocked randomisation with block sizes of m=6, 
4 and 2 are used within each stratum. Patients are allocated 
to clinicians based on locality and availability that is, not 
randomly. The randomisation is carried out remotely by the 
Pragmatic Clinical Trials Unit at Queen Mary, University of 
London, which is also responsible for database development 
and assists the team with data monitoring.
Trial arms
Arm 1: intervention
Who delivers the intervention
The intervention is delivered by clinicians from different 
backgrounds (eg, psychologists/assistant psychologists, 
social workers, nursing staff, occupational therapists and 
medical doctors), with a minimum level of experience 
and seniority equivalent to an NHS band 4. They take up 
a role of ‘social coach’ for the treated patient box 2.
Type and frequency of sessions
Social coaches meet patients at least three times but 
ideally monthly over the 6- month intervention period. 
During the first two sessions of the intervention, a struc-
tured eight step approach is followed and then revisited 
in follow- up meetings. Please see details of the eight step 
approach and of the intervention sessions in box 2.
The intervention starts with two initial face- to- face 
sessions (which can also occur via video conferencing), 
each lasting between 60 and 90 min. The main aim of these 
initial meetings is to introduce the intervention, explore 
participants’ social history and discuss preferences and 
options for activities. The participant then selects one 
social activity to focus on during the remaining meetings 
and actions are agreed. The subsequent meetings include 
discussions around challenges and progress and and 
take place monthly, lasting about 20 min each. The final 
meeting is face- to- face and is used as both a summary of 
progress and to plan for future social activities after the 
intervention. The intervention can be stopped at any 
time on participant request.
Training and supervision of social coaches
Social coaches are trained in one session lasting 3 hours, 
normally in a group format (although one- to- one sessions 
can be arranged). Training is provided by senior SCENE 
researchers.
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During the training coaches acquire knowledge of the 
structure and aims of the intervention, and of simple 
motivational interviewing (eg, identifying change talk) 
and solution focused therapy techniques (eg, identifying 
what has worked in the past). Scenarios in which barriers 
for the patients in engaging in new social activities may 
appear and strategies to overcome them are discussed.
Learning progress is assessed during the training and in 
the subsequent supervision, provided by senior members 
of the research team.
Clinicians receive updates on changes in options for 
activities from the local research team. They will also 
receive at least two supervision sessions by SCENE senior 
researchers.
Arm 2: control group
Patients in the control group are provided with informa-
tion about local options for social activities via a booklet 
sent to them in the post or handed over by a researcher. 
This is intended to control for the provision of infor-




The primary outcome is subjective quality of life, 
measured with the MANSA at the end of the intervention 
period (6 months after randomisation).
The MANSA has been widely used in research and cited 
in more than 850 research papers. The MANSA is brief 
with very high completion rates and excellent psycho-
metric properties.16
Mediator of effect on primary outcome
Number of social contacts in the previous week, measured 
at 6 months follow- up using the Social Contacts Assess-
ment (SCA).17 18
Secondary outcomes
 ► Social Contacts (SCA).17
 ► Psychopathological symptoms assessed with the Posi-
tive And Negative Syndrome Scale.19
 ► Social situation with the SIX.20
 ► Feeling of loneliness with the University of California, 
Los Angeles (UCLA) Loneliness Scale.21
 ► Time spent in social activities with the Time Use 
Survey.22
 ► Health- related quality of life with the EQ- 5D- 5L.23
 ► Service use with the Client Service Receipt Inven-
tory,24 and from NHS Digital datasets.25
Study outcomes and timepoints are summarised in 
table 1.
Patient and public involvement
A Lived Experience Advisory Panel (LEAP) has been set 
up and meets every 6 months to advise on study progress, 
review materials and support dissemination plans.
The LEAP has a central role in the preparation of study 
materials, design of practical procedures and dissemi-
nation. For example, LEAP members provided valuable 
feedback during the development of the intervention, 
and for facilitating recruitment and finding out about 
Box 2 SCENE Social coaching intervention: the eight step 
approach
(1) Introduction: The social coach and the patient introduce themselves.
2) Clarification of the remit of the intervention: The professional explains 
and discusses the focused remit of the intervention, i.e. that it aims to 
expand social networks and that all other therapeutic issues have to be 
addressed elsewhere.
(3) Exploration of past and current activities: The social coach explores 
past activities that involved social contacts; this should be done chrono-
logically covering the adult life time of the patient from the age of 15 
years onwards, and stepwise for periods of 5–10 years. At the end of 
the exploration, professional and patient go through the list of activities 
(if any) and discuss to what extent the patient enjoyed each activity. 
Solution focused therapy techniques (eg, identifying what went well and 
what worked) can be used.
(4) Motivation for change: The professional explores and discusses 
the patient’s motivation to change and expand their social networks. 
Motivational interviewing techniques (eg, identifying change talk) can 
be used.
(5) Options for activities: Professional and patient discuss which new ac-
tivities (or expanding existing ones, respectively) the patient considers.
(6) Information: The professional provides as much helpful information 
as possible about options in the given locality for patients’ preferred 
activities. Professional and patient discuss the practicalities and some-
times decide to obtain further information. In this step, the patient is 
encouraged and supported to find information him/herself. Yet, if this is 
a substantial hurdle, the professional provides as much direct support 
as needed.
(7) Consideration and decision: Once options have been identified, the 
patient is asked to consider taking it up. If the patient is ambivalent, 
patients are encouraged to take time, for example, a week until the next 
meeting or a phone call, to think about it.
(8) Definition of activity: Finally, the patient decides on the type of ac-
tivity and some specification of the actual steps (eg, twice per week 
attending a certain class, but not necessarily on which days), so that 
professional and patient can assess afterwards whether the activity has 
been completed or not. The task gets documented for the patient, for 
example, written on a piece of paper that the patient takes along.
How are the steps covered during the sessions?
There is some flexibility as to how much time each step takes and to 
what extent they are covered within the monthly sessions varies.
Session 1: Usually, the first meeting would end with steps 5 or 6.
Session 2: After the second meeting an activity is agreed upon. However, 
it is allowed that patients and professional leave the decision to a third 
session or take it during the first session if this is possible.
Session 3–6 (follow- up sessions): During follow- up sessions, social 
coach and patient discuss to what extent the activity has been done. 
The social coach provides positive feedback and—if required—deals 
with complete or partial perceived failure using solution focused tech-
niques (eg, emphasising what went well).
After 3 months (ie, session 3–4), the situation is re- evaluated. If the 
activity is working well, then this is monitored in further follow- up ses-
sions. In case professional and patient come to the conclusion that the 
originally planned activity does not work, a face- to- face meeting is ar-
ranged in which steps 4–8 of the initial meetings are repeated and a 
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available activities in the community. The chair of the 
LEAP is an expert by experience who attends regular 
meetings with the project team and is directly involved 
in parts of the research, in particular the interpretation 
of qualitative data. Findings from all work packages, 
including the intervention development are discussed 
with and influenced by the LEAP.
Internal pilot
The trial comprised an internal pilot with the aim of 
checking the feasibility of recruiting to target. The 
recruitment target for the internal pilot was 140 partic-
ipants representing an average rate of four participants 
per site per month for 5 months. This was achieved within 
the 5- month time frame.
Independent committees
The trial has an independent project steering committee 
and a data monitoring committee. Both include among 
their members one clinician/clinical researcher, one 
quantitative methodologist and one person with lived 
experience of mental illness.
Analyses
Statistical analysis
The primary outcome analysis will be the comparison 
of mean MANSA scores between treatment groups at 6 
months follow- up using a heteroscedastic partially nested 
mixed- effects model.26 This model will account for clus-
tering by treating clinician in the intervention arm, base-
line values of the outcome (MANSA) and site as covariates.
Secondary outcomes will be analysed using the same 
model as for the primary outcome or an equivalent model 
appropriate for the outcome type where the secondary 
outcome is not continuous. Differences in outcome 
measures between groups will be compared for 6 months, 
12 months and 18 months follow- up data. Additionally, 
repeated measures models comprising all four time 
points will be fitted. Baseline characteristics of patients 
will be tabulated by treatment arms.
The analysis will be on an intention- to- treat basis, and 
every effort will be made to collect complete data. If any 
outcome data are missing, available subject data only will 
be analysed (unbiased analysis under missing- at- random 
assumption); however, patterns of missing data will be 
explored, and a strategy for dealing with missing values 
will be articulated in the formal statistical analysis plan.
We are planning individual level single imputations 
(replacing missing values by a fixed value defined by a 
certain rule) analyses for partially completed primary 
outcome data to assess the uncertainty around the 
primary outcome analysis estimate. Further details of 
other sensitivity analyses planned will be outlined in the 
statistical analysis plan prior to analysis.
A mediator analysis will identify whether the effect on 
the primary outcome is mediated through expanded 
social networks (SCA) at 6 months, as hypothesised. The 
product of coefficients method, with a Sobel test and 
bootstrap standard errors will be used.27 Further media-
tion analyses will assess the mediation effect of increases 
in SCA at 6 months on patients’ MANSA score at 12 
months follow- up.
All analyses are incorporated into a statistical anal-
ysis plan, and allocation codes will not be released to 
the statistician before the analysis plan is signed off. All 
researchers involved in developing the analysis plan will 
remain blinded until the analysis plan is signed off.









  MANSA x x x x x
  Social contacts assessment x x x x x
  PANSS   x x x x
  Social situation   x x x x
  Loneliness   x x x x
  Time spent in social activities   x x x x
  EQ- 5D- 5L   x x x x
  Client service receipt inventory   x x x x
  Healthcare source use (NHS digital)   x x x x
Intervention participants only
  Semistructured interviews     x     
Social coaches
  Adherence schedule     x     
  Semistructured interviews     x     
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Sample size calculation
It is assumed that the proposed new intervention would 
be implemented and funded across the NHS only if it 
achieved at least a medium sized effect. An effect size 
of 0.35 is equivalent to an improvement of satisfaction 
ratings on the MANSA of at least one scale point (on 
a 7- point scale) for 4 out of a total of 12 life domains. 
An improvement of quality of life in four life domains is 
usually regarded as a meaningful difference to patients’ 
life.16
For detecting such an effect size with 90% power, 
assuming a conservative intraclass correlation coefficient 
(ICC) of 0.07 for patients treated by the same professional 
in the intervention group, 229 patients in the interven-
tion group and 229 in the control group will be required 
(total sample=458). A 1:1 allocation ratio has been 
chosen for organisational ease. This requires eight addi-
tional patients to be recruited compared with the abso-
lute minimum required sample size with slightly uneven 
groups. A drop- out rate (from the study) at 6 months 
follow- up of 20% (in line with recent trials of similar inter-
ventions with the same patient group) (VOLUME trial) 
was assumed.18 The sample size calculation was based on 
10 patients being treated and followed- up per clinician 
on average. Based on recruiting 12 patients per clinician 
the final total sample size target was 576 patients (288 per 
arm). Recruitment and intervention delivery to SCENE 
were paused during the COVID- 19 pandemic making a 
study extension necessary (see the section Impact of the 
COVID- 19 pandemic). For this a sample size recalculation 
was conducted using values observed so far for two quan-
tities. The drop- out rate was inflated from 20% to 25% 
(actual rate to date 24%). Cluster size in the interven-
tion arm was reduced from 10 to 3 patients per treating 
professional on average allowing for observed variability 
in patients per professional. Using these estimates the 
updated total number of patients to recruit is 504.
Qualitative process evaluation
A qualitative process evaluation will be conducted, 
employing semistructured interviews with a number of 
purposively selected patients and social coaches. Inter-
views will be transcribed and analysed using thematic 
analysis.28
We will interview 40 patients in the experimental group 
to explore experiences of the intervention and descrip-
tions of qualitative changes in their social network, contacts 
and activities. A topic guide for interviews was developed 
with input from the LEAP. Interviews will be conducted 
after the end of the 6- month outcome assessment, so 
that the interviews do not interfere with the effects of the 
intervention in influencing the primary outcome (quality 
of life at 6 months). Unblinded researchers will identify 
participants, conduct the interviews and manage qualita-
tive data, so researchers assessing outcomes remain blind 
to allocation.
We will use purposive sampling, to include patients who 
differ according to gender, whether they live in urban or 
rural settings and whether or not they completed the 
intervention. Sampling of social coaches will include 
those who have seen more than three patients and those 
who have seen fewer.
Adherence to manual
Adherence to manual will be assessed through our adher-
ence checklist. Routine documentation and audiotapes 
of patient–professional meetings (for consenting partic-
ipants) will be compared against the clinician- reported 
adherence schedule to check reliability. This is a self- 
reported checklist of whether and how the different steps 
of the intervention (box 2) are addressed. Clinicians will 
have addressed all the eight steps of the intervention and 
conducted at least three sessions with a given patient for 
the intervention to be deemed as completed.
Economic evaluation
The within trial analysis will adopt the NHS and Personal 
Social Services perspective to assess the cost- effectiveness 
of the psychosocial intervention for patients with psychosis 
compared with best standard practice.29 The evaluation 
will focus on the 18 months from baseline until the end 
of the follow- up period. The analysis will adhere to guide-
lines for good economic evaluation practice as outlined 
in Ramsey et al30 and Sanders et al.31
Resource- use associated with delivery of the interven-
tions in both trial arms will be identified using a specially 
designed intervention implementation form. Partici-
pants’ use of health services, including mental health and 
hospital care, will be extracted from the NHS Digital data-
base. All participants will be asked to complete a modified 
version of the Client Services Receipt Inventory to obtain 
information about their of other psychosocial interven-
tions, medication and receipt of informal care from fami-
lies and friends. The quantities of all resource use will 
be combined with unit costs to generate cost at the indi-
vidual participant level. Unit costs will be obtained from 
various sources, including a specially designed coach 
demographics questionnaire, NHS Reference costs,32 
Unit Costs of Health and Social Care,33 NHS drug Tariff34 
and the UK earnings data.35
As for outcomes, the primary outcome measure for the 
economic evaluation will be collected using the EQ- 5D- 5L 
instrument.23 We will calculate the participant- level 
quality- adjusted life- years (QALYs) and use the EQ- 5D- 5L 
data with the area- under- the- curve approach.36 The 
secondary outcome will be measured using the MANSA. 
The time points for collecting costs and outcome data are 
reported in table 1.
Both costs and outcomes occurring during the last 
6 months of the follow- up period will be discounted at 
3.5% in line with the NICE recommendation.29 Costs 
and outcome data will be analysed by treatment alloca-
tion, and differences between trial arms will be estimated 
over 18 months, adjusting for baseline differences using 
regression analysis. We will select an appropriate method 
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Cost–utility analysis and cost- effectiveness analysis will 
be applied in the economic evaluation. In the cost–utility 
analysis, the estimates of incremental cost- effectiveness 
ratio (ICER) for the psychosocial intervention compared 
with best standard practice will be presented against the 
decision- maker’s willingness to pay a value of £20 000–£30 
000 per QALY.23 To report the uncertainty of the point 
estimate of ICER, we will use the non- parametric boot-
strap approach to estimate the CI around the ICER. We 
will also present the probability that the intervention is 
cost- effective against a range of decision makers’ willing-
ness to pay value using the cost effectiveness acceptability 
curve. In the cost- effectiveness analysis, we will calculate 
the incremental cost per unit change on the MANSA 
scale and uncertainty surrounding the ratio.
A number of sensitivity analyses to assess the impact of 
key assumptions as well as uncertainty with key parame-
ters in the economic evaluation will be conducted to (1) 
explore the impact of alternative assumptions about the 
missing data mechanism; (2) consider uncertainty in 
the most important cost drivers to assess the impact of 
healthcare use; (3) use a broader analytical perspective 
by including additional costs for informal care; (4) use 
0–6 months from randomisation as the time period for 
economic evaluation.
Ethics and dissemination
The study was reviewed and a favourable opinion received 
from the London Hampstead NHS Research Ethics 
Committee (19/LO/0088). Any serious adverse events 
are recorded in specific forms and their relationship with 
the intervention are adjudicated by site leads who are all 
senior clinicians. Written informed consent is provided 
by participants after discussion with researchers. A model 
consent form is enclosed as a online supplemental 
document.
Any personal information stored in locked cabinets 
on NHS premises if in paper version, and encrypted if in 
electronic version. Dataset will be accessed by the study 
team and after the primary analysis may be made avail-
able to other parties subject to data sharing agreements.
Throughout all phases of the research, we will dissem-
inate information about the activities of the programme 
through social media and a project specific website 
(http:// scene. elft. nhs. uk/) in order to reach a wider 
public audience. Authorship guidelines for outputs will 
follow the International Committee of Medical Journal 
Editors (ICMJE) guidelines.
When results become available, they will be dissemi-
nated through:
 ► Scientific publications in peer- reviewed open- access 
journals.
 ► Presentations at national and international confer-
ences and to professional and non- professional audi-
ences at appropriate events.
 ► Existing networks, including but not limited to the 
WHO, the benchmarking network in mental health, 
organisations involved in Quality Improvement 
programmes and the professional networks of the 
programme management group members.
Impact of the COVID-19 pandemic
Following the outbreak of COVID- 19 in the UK, recruit-
ment was stopped from 16 March 2020 to 1 October 2020. 
We decided to stop the intervention delivery from 16 
March 2020 to 21 August 2020 in accordance with social 
distancing guidelines at that time.
We added an additional follow- up at 10 months from 
randomisation for those participants who had already 
been randomised when the study was stopped, but had 
not completed the treatment period. A sensitivity analysis 
will consider end- of- treatment as the outcome of compar-
ison, and hence include the assessment of quality of life at 
10 months from randomisation rather than at 6 months 
for these participants.
We created additional adapted versions (used sepa-
rately from the standard ones) of the SCA and of the 
Time Use Survey and data collected will be analysed to 
capture online social contacts and activities throughout 
the trial.
The recruitment and randomisation of participants 
was resumed on 1 October 2020. Additional instructions 
to social coaches were provided on physical distancing 
with patients and on how to encourage social activities 
which are either online or can be carried in accordance 
with different scenarios and different physical distancing 
directives.
Research follow- up of participants at different time-
points was never stopped and continued over the phone 
or via videoconferencing.
We have calculated that 70 participants may have 
been especially affected by the COVID- 19 pandemic in 
that their primary outcome was assessed at a time when 
restrictions meant that they could not meet more than 
one person outside of their household.
To adjust for any pandemic effects on the interven-
tion itself, the outcomes or both, a sensitivity analysis will 
adopt a mixed- effects model approach, grouping partici-
pants according to the physical distancing guidance that 
they have been exposed to. Individual treatment effect 
estimates of participant groups with different levels of 
exposure will be calculated.
DISCUSSION
This study addresses a gap in mental healthcare provision, 
that is, the lack of treatments available to help patients 
overcome their social isolation.4 It has broad inclusion 
criteria and is carried out across a large number of urban, 
semiurban and rural sites. This will allow to control by 
design a number of patient- level (eg, financial and clin-
ical status) and area- level characteristics (eg, availability 
of affordable activities, distance and travel required 
to access them) which might influence intervention 
effectiveness. The active control condition, that is, the 
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activities, does not only control for service attention to 
social activity and information provision, but also argu-
ably represents a reflection of best current practice.
The methodological choices made when designing the 
study come with some limitations:
 ► Older people and those who are not fluent in the 
language of their country of residence encounter addi-
tional barriers to socialisation. Hence, we restricted 
inclusion criteria to patients with psychotic disorders 
of working age and to those who are fluent in English, 
to limit heterogeneity of our sample. Future trials 
and/or implementation studies should target these 
populations specifically.
 ► The new intervention has been implemented in 
services directly as part of the trial. Social coaches are 
trained but do not have previous experience in deliv-
ering this type of approach.
In addition to this, the COVID- 19 outbreak meant that 
more of the intervention has to be delivered remotely 
than originally envisaged, and we do not know whether 
and how that will impact on outcomes. We have a sensi-
tivity analysis to estimate this as explained in detail in the 
following paragraph.
If the intervention is found to be effective in increasing 
social contacts and improving quality of life, it can 
promptly become part of the therapeutic armamentarium 
of mental health services. The flexibility of the approach, 
which can be delivered by different type of professionals, 
might facilitate its uptake within the ever evolving land-
scape of mental health services. In line with the design of 
the trial, we do not intend for the social coach to become 
be a new professional role in itself. Instead, the function 
of social coaches can be taken on by different profes-
sionals and exercised along with other clinical activities.
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